terfenadine has been researched along with Experimental Mammary Neoplasms in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurrapu, S | 1 |
| Jonnalagadda, SK | 1 |
| Alam, MA | 1 |
| Ronayne, CT | 1 |
| Nelson, GL | 1 |
| Solano, LN | 1 |
| Lueth, EA | 1 |
| Drewes, LR | 1 |
| Mereddy, VR | 1 |
1 other study available for terfenadine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coumarins; D | 2016 |